A Transcriptomic Biomarker to Quantify Systemic Inflammation in Sepsis — A Prospective Multicenter Phase II Diagnostic Study

[1]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[2]  T. van der Poll,et al.  A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts , 2015, PLoS medicine.

[3]  A. Zwinderman,et al.  A molecular biomarker to diagnose community-acquired pneumonia on intensive care unit admission. , 2015, American journal of respiratory and critical care medicine.

[4]  S. Opal,et al.  Sepsis: a roadmap for future research. , 2015, The Lancet. Infectious diseases.

[5]  Michael Bailey,et al.  Systemic inflammatory response syndrome criteria in defining severe sepsis. , 2015, The New England journal of medicine.

[6]  Eugene Kolker,et al.  MOPED 2.5--an integrated multi-omics resource: multi-omics profiling expression database now includes transcriptomics data. , 2014, Omics : a journal of integrative biology.

[7]  E. Ruokonen,et al.  A Multibiomarker-Based Outcome Risk Stratification Model for Adult Septic Shock* , 2014, Critical care medicine.

[8]  P. Velilla,et al.  Immunological Characterization of Compensatory Anti-Inflammatory Response Syndrome in Patients With Severe Sepsis: A Longitudinal Study* , 2014, Critical care medicine.

[9]  R. Hotchkiss,et al.  The changing immune system in sepsis , 2013, Virulence.

[10]  David R. Booth,et al.  Identifying Key Regulatory Genes in the Whole Blood of Septic Patients to Monitor Underlying Immune Dysfunctions , 2013, Shock.

[11]  R. Hotchkiss,et al.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. , 2013, The Lancet. Infectious diseases.

[12]  E. Giamarellos‐Bourboulis,et al.  The immune response to severe bacterial infections: consequences for therapy , 2012, Expert review of anti-infective therapy.

[13]  Ruslan Medzhitov,et al.  Disease Tolerance as a Defense Strategy , 2012, Science.

[14]  R. Hotchkiss,et al.  Immunosuppression in patients who die of sepsis and multiple organ failure. , 2011, JAMA.

[15]  John D. Storey,et al.  A genomic storm in critically injured humans , 2011, The Journal of experimental medicine.

[16]  G. Kumar,et al.  Nationwide trends of severe sepsis in the 21st century (2000-2007). , 2011, Chest.

[17]  Ronald G. Tompkins,et al.  Dissecting Inflammatory Complications in Critically Injured Patients by Within-Patient Gene Expression Changes: A Longitudinal Clinical Genomics Study , 2011, PLoS medicine.

[18]  Fei Wang,et al.  Granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis: a meta-analysis , 2011, Critical care.

[19]  G. Rubenfeld,et al.  Critical care and the global burden of critical illness in adults , 2010, The Lancet.

[20]  J. Vincent,et al.  Sepsis biomarkers: a review , 2010, Critical care.

[21]  W. Junger,et al.  Circulating Mitochondrial DAMPs Cause Inflammatory Responses to Injury , 2009, Nature.

[22]  S. Opal,et al.  Antibiotic usage and resistance: gaining or losing ground on infections in critically ill patients? , 2009, JAMA.

[23]  Jordi Rello,et al.  International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.

[24]  Steven B. Johnson,et al.  DIFFERENTIAL EXPRESSION OF TOLL-LIKE RECEPTOR GENES: SEPSIS COMPARED WITH STERILE INFLAMMATION 1 DAY BEFORE SEPSIS DIAGNOSIS , 2009, Shock.

[25]  J. Cavaillon,et al.  Compensatory anti-inflammatory response syndrome , 2008, Thrombosis and Haemostasis.

[26]  Jay Steingrub,et al.  International study of the prevalence and outcomes of infection in intensive care units , 2009 .

[27]  Anthony S McLean,et al.  The use of gene-expression profiling to identify candidate genes in human sepsis. , 2007, American journal of respiratory and critical care medicine.

[28]  Steven B. Johnson,et al.  Gene Expression Profiles Differentiate Between Sterile SIRS and Early Sepsis , 2007, Annals of surgery.

[29]  M. Tsuang,et al.  Shifting emphasis from pharmacogenomics to theragnostics , 2006, Nature Biotechnology.

[30]  H. Baker,et al.  Functional genomics and gene expression profiling in sepsis: beyond class prediction. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  John D. Storey,et al.  A network-based analysis of systemic inflammation in humans , 2005, Nature.

[32]  Jonathan Cohen,et al.  The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit , 2005, Critical care medicine.

[33]  M. Singer,et al.  Treating Critical Illness: The Importance of First Doing No Harm , 2005, PLoS medicine.

[34]  M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive care medicine.

[35]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[36]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[37]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.